                         SEQUENCE LISTING

<110>  CELL THERAPY LIMITED
 
<120>  SIRNA MICROBUBBLE

<130>  N400521WO

<150>  1511459.8
<151>  2015-06-30

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Artificial siRNA sequence for use in the invention

<400>  1
gcaggaagaa cucaaguuut t                                                 21


<210>  2
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Artificial siRNA sequence for use in the invention

<400>  2
aaacuugagu ucuuccugct t                                                 21


<210>  3
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Artificial siRNA sequence for use in the invention

<400>  3
acaguacguu acuagccuut t                                                 21


<210>  4
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Artificial siRNA sequence for use in the invention

<400>  4
aaggcuagua acguacugut t                                                 21


<210>  5
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Artificial siRNA sequence for use in the invention

<400>  5
gaaucaguca acguguugut t                                                 21


<210>  6
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Artificial siRNA sequence for use in the invention

<400>  6
acaacacguu gacugauuct t                                                 21


<210>  7
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Artificial siRNA sequence for use in the invention

<400>  7
agcacuggag aaaucaucat t                                                 21


<210>  8
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Artificial siRNA sequence for use in the invention

<400>  8
ugaugauuuc uccagugcut t                                                 21


